Opinion
New weight loss drugs raise questions of access, costs
New, popular injectable weight loss drugs — GLP-1 drugs — are highly effective at reducing obesity and, probably, the health risks posed by obesity. Yet the drugs are so expensive that insurers are often choosing between two bad options: restricting access or raising consumer costs.
Popular weight loss drugs like Ozempic might be able to help with substance abuse, according to new research on people ...
I always had a massive appetite and most of my life, I was able to eat what I wanted. I never worried about my size, assuming ...
Zmyra is known as the top over-the-counter alternative to Wegovy for weight loss. This natural supplement packs a punch with ...
Unemployed people will be given weight-loss jabs under Government plans to get them back to work. Wes Streeting, the Health ...
As with any new drug, parents and doctors may worry that the use of GLP-1 weight-loss meds by children and teens might raise ...
Wes Streeting responded to a Sky News report which found the NHS rollout of the "game-changing" weightloss drug has been slower than planned by saying it could risk fuelling a rise in eating disorders ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback